Similar articles

• Short QT syndrome: pharmacological treatment.

  Gaita F, Giustetto C, Bianchi F, Schimpf R, Haissaguerre M, Calò L, Brugada R, Antzelevitch C, Borggrefe M, Wolpert C. Gaita F, et al. J Am Coll Cardiol. 2004 Apr 21;43(8):1494-9. doi: 10.1016/j.jacc.2004.02.034. J Am Coll Cardiol. 2004. PMID: 15093889 Clinical Trial.
• Hydroquinidine Prevents Life-Threatening Arrhythmic Events in Patients With Short QT Syndrome.

  Mazzanti A, Maragna R, Vacanti G, Kostopoulou A, Marino M, Monteforte N, Bloise R, Underwood K, Tibollo V, Pagan E, Napolitano C, Bellazzi R, Bagnardi V, Priori SG. Mazzanti A, et al. J Am Coll Cardiol. 2017 Dec 19;70(24):3010-3015. doi: 10.1016/j.jacc.2017.10.025. J Am Coll Cardiol. 2017. PMID: 29241489
• Hydroquinidine therapy in Brugada syndrome.

  Hermida JS, Denjoy I, Clerc J, Extramiana F, Jarry G, Milliez P, Guicheney P, Di Fusco S, Rey JL, Cauchemez B, Leenhardt A. Hermida JS, et al. J Am Coll Cardiol. 2004 May 19;43(10):1853-60. doi: 10.1016/j.jacc.2003.12.046. J Am Coll Cardiol. 2004. PMID: 15145111
• The Role of Quinidine in the Pharmacological Therapy of Ventricular Arrhythmias 'Quinidine'.

  Bozic B, Uzelac TV, Kezic A, Bajcetic M. Bozic B, et al. Mini Rev Med Chem. 2018;18(6):468-475. doi: 10.2174/1389557517666170707110450. Mini Rev Med Chem. 2018. PMID: 28685701 Review.
• Quinidine revisited.

  Yang F, Hanon S, Lam P, Schweitzer P. Yang F, et al. Am J Med. 2009 Apr;122(4):317-21. doi: 10.1016/j.amjmed.2008.11.019. Epub 2009 Feb 25. Am J Med. 2009. PMID: 19249010 Review.